The Living with Pulmonary Fibrosis questionnaire in progressive fibrosing interstitial lung disease

The Living with Pulmonary Fibrosis questionnaire in progressive fibrosing interstitial lung disease

The Living with Idiopathic Pulmonary Fibrosis (L-IPF) questionnaire was developed with substantial input from patients with idiopathic pulmonary fibrosis (IPF) to assess symptoms and health-related quality of life (HRQoL). Because IPF is the prototypical chronic fibrosing interstitial lung disease (...

Full description

Bibliographic Details
Main Authors:	Jeffrey Swigris, Katelyn Cutts, Natalia Male, Michael Baldwin, Klaus B. Rohr, Donald M. Bushnell
Format:	Article
Language:	English
Published:	European Respiratory Society 2021-05-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/7/2/00145-2020.full

Similar Items

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
by: Sergio Harari
Published: (2018-12-01)

Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures
by: Marlies Wijsenbeek, et al.
Published: (2022-05-01)

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases
by: Jeffrey J. Swigris, et al.
Published: (2018-12-01)

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
by: Paolo Cameli, et al.
Published: (2022-08-01)

Progression of fibrosing interstitial lung disease
by: Alyson W. Wong, et al.
Published: (2020-01-01)

Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?
by: Jeffrey J Swigris, et al.
Published: (2023-12-01)

Biomarkers of Progressive Fibrosing Interstitial Lung Diseases
by: E. V. Bolotova, et al.
Published: (2023-11-01)

Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype
by: L. P. Ananieva, et al.
Published: (2021-01-01)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
by: Martin Kolb, et al.
Published: (2018-12-01)

The natural history of progressive fibrosing interstitial lung diseases
by: Martin Kolb, et al.
Published: (2019-03-01)

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
by: Xianqiu Chen, et al.
Published: (2021-10-01)

The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
by: Ahmad Abu Qubo, et al.
Published: (2022-01-01)

Role of imaging in progressive-fibrosing interstitial lung diseases
by: Simon L.F. Walsh, et al.
Published: (2018-12-01)

Pharmacological treatment of idiopathic pulmonary fibrosis and fibrosing interstitial lung diseases: current trends and future directions
by: Won-Il Choi
Published: (2021-03-01)

Diffuse pulmonary ossification associated with fibrosing interstitial lung disease
by: Badreeddine Alami, et al.
Published: (2019-01-01)

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.
by: Marius M Hoeper, et al.
Published: (2015-01-01)

Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective
by: Carlo Albera, et al.
Published: (2021-09-01)

Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease.
by: Mayuko Watase, et al.
Published: (2023-01-01)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
by: Vincent Cottin, et al.
Published: (2021-03-01)

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
by: Byoung Soo Kwon, et al.
Published: (2021-10-01)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
by: Carla R. Copeland, et al.
Published: (2021-10-01)

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
by: Vincent Cottin
Published: (2019-10-01)

Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
by: Julien Guiot, et al.
Published: (2023-09-01)

Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives
by: Gould Michael K, et al.
Published: (2005-10-01)

Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
by: Giles Dixon, et al.
Published: (2024-01-01)

Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study
by: Anna Denis, et al.
Published: (2022-11-01)

Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases
by: Colin Holtze, et al.
Published: (2018-12-01)

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
by: Vincent Cottin, et al.
Published: (2018-12-01)

Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
by: Ole Hilberg, et al.
Published: (2022-01-01)

Validation of the King’s Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis
by: Thomas Skovhus Prior, et al.
Published: (2019-12-01)

Fibrosing interstitial lung diseases: knowns and unknowns
by: Vincent Cottin, et al.
Published: (2019-02-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
by: Maria S. Nashatyreva, et al.
Published: (2023-01-01)

Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study
by: Marco Sebastiani, et al.
Published: (2023-11-01)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
by: John N. Shumar, et al.
Published: (2021-05-01)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
by: Atsushi Kumanogoh, et al.
Published: (2023-01-01)

Present and future perspectives in early diagnosis and monitoring for progressive fibrosing interstitial lung diseases
by: Stefan Cristian Stanel, et al.
Published: (2023-02-01)

Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence
by: Luca Richeldi, et al.
Published: (2018-12-01)

Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response
by: Willis S. Bowman, et al.
Published: (2021-05-01)

Case Report: Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia
by: Michiko Takimoto-Sato, et al.
Published: (2022-05-01)

Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage
by: Laurens J. De Sadeleer, et al.
Published: (2020-06-01)